Biomerica, Inc.
BMRA
$2.18
$0.020.93%
NASDAQ
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -18.43% | -12.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.43% | -12.32% | |||
| Cost of Revenue | -11.04% | 21.23% | |||
| Gross Profit | -186.27% | -87.97% | |||
| SG&A Expenses | -12.59% | -7.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.54% | 3.40% | |||
| Operating Income | 5.46% | -22.81% | |||
| Income Before Tax | 0.84% | -26,400.00% | |||
| Income Tax Expenses | 60.00% | 66.67% | |||
| Earnings from Continuing Operations | 0.61% | -66,100.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.61% | -66,100.00% | |||
| EBIT | 5.46% | -22.81% | |||
| EBITDA | 5.54% | -23.22% | |||
| EPS Basic | 3.99% | -56,837.50% | |||
| Normalized Basic EPS | 4.21% | -23,650.00% | |||
| EPS Diluted | 3.06% | -56,837.50% | |||
| Normalized Diluted EPS | 4.21% | -23,650.00% | |||
| Average Basic Shares Outstanding | 3.51% | 10.21% | |||
| Average Diluted Shares Outstanding | 3.51% | 10.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||